Novel synthetic antimicrobial peptides against Streptococcus mutans

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 4, 2007, Pages 1351-1358

  He, Jian ^a   Eckert, Randal ^a   Pharm, Thanh ^a   Simanian, Maurice D ^a   Hu, Chuhong ^a   Yarbrough, Daniel K ^a   Qi, Fengxia ^a   Anderson, Maxwell H ^b   Shi, Wenyuan ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b C3 Jian Inc   (United States)

^c UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE LIBRARY; POLYPEPTIDE ANTIBIOTIC AGENT;

ARTICLE; BACTERIUM ISOLATE; DENTAL CARIES; HYDROPHOBICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS MUTANS;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; HUMANS; MOUTH; PEPTIDES; STREPTOCOCCUS MUTANS;

EID: 34247146272     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01270-06     Document Type: Article

References (47)

1. Ajdic, D., W. M. McShan, R. E. McLaughlin, G. Savic, J. Chang, M. B. Carson, C. Primeaux, R. Tian, S. Kenton, H. Jia, S. Lin, Y. Qian, S. Li, H. Zhu, F. Najar, H. Lai, J. White, B. A. Roe, and J. J. Ferretti. 2002. Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen. Proc. Natl. Acad. Sci. USA 99:14434-14439.
2. Anderson, M. H., and W. Shi. 2006. A probiotic approach to caries management. Pediatr. Dent. 28:151-153, 192-198.
3. Blondelle, S. E., and R. A. Houghten. 1996. Novel antimicrobial compounds identified using synthetic combinatorial library technology. Trends Biotechnol. 14:60-65.
4. Blondelle, S. E., and K. Lohner. 2000. Combinatorial libraries: a tool to design antimicrobial and antifungal peptide analogues having lytic specificities for structure-activity relationship studies. Biopolymers 55:74-87.
5. Blondelle, S. E., E. Perez-Paya, and R. A. Houghten. 1996. Synthetic combinatorial libraries: novel discovery strategy for identification of antimicrobial agents. Antimicrob. Agents Chemother. 40:1067-1071.
6. Brogden, K. A. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250.
7. Brogden, K. A., M. Ackermann, P. B. McCray, Jr., and B. F. Tack. 2003. Antimicrobial peptides in animals and their role in host defences. Int. J. Antimicrob. Agents 22:465-478.
8. Chan, D. I., E. J. Prenner, and H. J. Vogel. 2006. Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim. Biophys. Acta 1758:1184-1202.
9. Deslouches, B., S. M. Phadke, V. Lazarevic, M. Cascio, K. Islam, R. C. Montelaro, and T. A. Mietzner. 2005. De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrob. Agents Chemother. 49:316-322.
10. Devi, A., N. Sitaram, and R. Nagaraj. 1998. Structural features of helical aggregates of antibacterial peptides via simulated annealing and molecular modeling. J. Biomol. Struct. Dyn. 15:653-651.
11. Diamond, G. 2001. Natures antibiotics: the potential of antimicrobial peptides as new drugs. Biologist (London) 48:209-212.
12. Reference deleted.
13. Eckert, R., K. M. Brady, E. P. Greenberg, F. Qi, D. K. Yarbrough, J. He, I. McHardy, M. H. Anderson, and W. Shi. 2006. Enhancement of antimicrobial activity against Pseudomonas aeruginosa by coadministration of G10KHc and tobramycin. Antimicrob. Agents Chemother. 50:3833-3838.
14. Eckert, R., J. He, D. K. Yarbrough, F. Qi, M. H. Anderson, and W. Shi. 2006. Targeted killing of Streptococcus mutans by a pheromone-guided "smart" antimicrobial peptide. Antimicrob. Agents Chemother. 50:3651-3657.
15. Eckert, R., F. Qi, D. K. Yarbrough, J. He, M. H. Anderson, and W. Shi. 2006. Adding selectivity to antimicrobial peptides: rational design of a multidomain peptide against Pseudomonas spp. Antimicrob. Agents Chemother. 50:1480-1488.
16. Egland, P. G., R. J. Palmer, Jr., and P. E. Kolenbrander. 2004. Interspecies communication in Streptococcus gordonii-Veillonella atypica biofilms: signaling in flow conditions requires juxtaposition. Proc. Natl. Acad. Sci. USA 101:16917-16922.
17. Fauchere, J. L., and V. E. Pliska. 1983. Hydrophobic parameters p of amino-acid side chains from the partitioning of N-acetyl-amino-acid amides. Eur. J. Med. Chem. 18:369-375.
18. Hancock, R. E., and R. Lehrer. 1998. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16:82-88.
19. Hong, S. Y., T. G. Park, and K. H. Lee. 2001. The effect of charge increase on the specificity and activity of a short antimicrobial peptide. Peptides 22:1669-1674.
20. Jing, W., H. N. Hunter, J. Hagel, and H. J. Vogel. 2003. The structure of the antimicrobial peptide Ac-RRWWRF-NH2 bound to micelles and its interactions with phospholipid bilayers. J. Pept. Res. 61:219-229.
21. Keene, H. J., and I. L. Shklair. 1974. Relationship of Streptococcus mutans carrier status to the development of carious lesions in initially cariesfree recruits. J. Dent. Res. 53:1295.
22. Kiyota, T., S. Lee, and G. Sugihara. 1996. Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes. Biochemistry 35:13196-13204.
23. Kuramitsu, H., and L. Ingersoll. 1977. Molecular basis for the different sucrose-dependent adherence properties of Streptococcus mutans and Streptococcus sanguis. Infect. Immun. 17:330-337.
24. Lee, K. H. 2002. Development of short antimicrobial peptides derived from host defense peptides or by combinatorial libraries. Curr. Pharm. Des. 8:795-813.
25. Lehrer, R. I., and T. Ganz. 2002. Defensins of vertebrate animals. Curr. Opin. Immunol. 14:96-102.
26. Liu, L.-P., and C. M. Deber. 1998. Uncoupling hydrophobicity and helicity in transmembrane segments. Alpha-helical propensities of the amino acids in non-polar environments. J. Biol. Chem. 273:23645-23648.
27. Loesche, W. J. 1986. Role of Streptococcus mutans in human dental decay. Microbiol. Rev. 50:353-380.
28. Marr, A. K., W. J. Gooderham, and R. E. Hancock. 2006. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol. 6:468-472.
29. Mecozzi, S., A. P. West, Jr., and D. A. Dougherty. 1996. Cation-pi interactions in aromatics of biological and medicinal interest: electrostatic potential surfaces as a useful qualitative guide. Proc. Natl. Acad. Sci. USA 93:10566-10571.
30. Reference deleted.
31. National Institutes of Health. 2000. Oral health in America: a report of the Surgeon General. Department of Health and Human Services, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD.
32. Qi, F., J. Kreth, C. M. Levesque, O. Kay, R. W. Mair, W. Shi, D. G. Cvitkovitch, and S. D. Goodman. 2005. Peptide pheromone induced cell death of Streptococcus mutans. FEMS Microbiol. Lett. 251:321-326.
33. Rogers, A. H. 1975. Bacteriocin types of Streptococcus mutans in human mouths. Arch. Oral Biol. 20:853-858.
34. Sal-Man, N., Z. Oren, and Y. Shai. 2002. Preassembly of membrane-active peptides is an important factor in their selectivity toward target cells. Biochemistry 41:11921-11930.
35. Sawai, M. V., A. J. Waring, W. R. Kearney, P. B. McCray, Jr., W. R. Forsyth, R. I. Lehrer, and B. F. Tack. 2002. Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides. Protein Eng. 15:225-232.
36. Schiffer, M., and A. B. Edmundson. 1967. Use of helical wheels to represent the structures of proteins and to identify segments with helical potential. Biophys. J. 7:121-135.
37. Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462:55-70.
38. Shai, Y. 2002. Mode of action of membrane active antimicrobial peptides. Biopolymers 66:236-248.
39. Szynol, A., J. J. de Haard, E. C. Veerman, J. J. de Soet, and A. V. van Nieuw Amerongen. 2006. Design of a peptibody consisting of the antimicrobial peptide dhvar5 and a llama variable heavy-chain antibody fragment. Chem. Biol. Drug Des. 67:425-431.
40. Tack, B. F., M. V. Sawai, W. R. Kearney, A. D. Robertson, M. A. Sherman, W. Wang, T. Hong, L. M. Boo, H. Wu, A. J. Waring, and R. I. Lehrer. 2002. SMAP-29 has two LPS-binding sites and a central hinge. Eur. J. Biochem. 269:1181-1189.
41. Thorgeirsson, T. E., C. J. Russell, D. S. King, and Y. K. Shin. 1996. Direct determination of the membrane affinities of individual amino acids. Biochemistry 35:1803-1809.
42. Tossi, A., L. Sandri, and A. Giangaspero. 2000. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55:4-30.
43. Washington State Department of Health. 2002. Infectious diseases-dental caries. Washington State Department of Health, Olympia, WA.
44. Wei, S. Y., J. M. Wu, Y. Y. Kuo, H. L. Chen, B. S. Yip, S. R. Tzeng, and J. W. Cheng. 2006. Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity. J. Bacteriol. 188:328-334.
45. Wimmer, R., K. K. Andersen, B. Vad, M. Davidsen, S. Molgaard, L. W. Nesgaard, H. H. Kristensen, and D. E. Otzen. 2006. Versatile interactions of the antimicrobial peptide novispirin with detergents and lipids. Biochemistry 45:481-497.
46. Zelezetsky, I., U. Pag, H. G. Sahl, and A. Tossi. 2005. Tuning the biological properties of amphipathic alpha-helical antimicrobial peptides: rational use of minimal amino acid substitutions. Peptides 26:2368-2376.
47. Zhang, L., A. Rozek, and R. E. Hancock. 2001. Interaction of cationic antimicrobial peptides with model membranes. J. Biol. Chem. 276:35714-35722.